472 related articles for article (PubMed ID: 12481159)
21. Beta-catenin--a linchpin in colorectal carcinogenesis?
Wong NA; Pignatelli M
Am J Pathol; 2002 Feb; 160(2):389-401. PubMed ID: 11839557
[TBL] [Abstract][Full Text] [Related]
22. Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines.
Boon EM; Keller JJ; Wormhoudt TA; Giardiello FM; Offerhaus GJ; van der Neut R; Pals ST
Br J Cancer; 2004 Jan; 90(1):224-9. PubMed ID: 14710233
[TBL] [Abstract][Full Text] [Related]
23. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
24. The significance of the Wnt pathway in the pathology of human cancers.
Karim R; Tse G; Putti T; Scolyer R; Lee S
Pathology; 2004 Apr; 36(2):120-8. PubMed ID: 15203747
[TBL] [Abstract][Full Text] [Related]
25. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.
Kolligs FT; Hu G; Dang CV; Fearon ER
Mol Cell Biol; 1999 Aug; 19(8):5696-706. PubMed ID: 10409758
[TBL] [Abstract][Full Text] [Related]
26. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.
Wielenga VJ; Smits R; Korinek V; Smit L; Kielman M; Fodde R; Clevers H; Pals ST
Am J Pathol; 1999 Feb; 154(2):515-23. PubMed ID: 10027409
[TBL] [Abstract][Full Text] [Related]
27. [The role of APC in colonic cancerogenesis: zeroing in on Myc].
Jeanteur P
Bull Cancer; 1998 Nov; 85(11):925-8. PubMed ID: 9951419
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta.
Li J; Mizukami Y; Zhang X; Jo WS; Chung DC
Gastroenterology; 2005 Jun; 128(7):1907-18. PubMed ID: 15940626
[TBL] [Abstract][Full Text] [Related]
29. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
[TBL] [Abstract][Full Text] [Related]
30. Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells.
Helmbrecht K; Kispert A; von Wasielewski R; Brabant G
Endocrinology; 2001 Dec; 142(12):5261-6. PubMed ID: 11713224
[TBL] [Abstract][Full Text] [Related]
31. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.
Wong SC; Lo SF; Lee KC; Yam JW; Chan JK; Wendy Hsiao WL
J Pathol; 2002 Feb; 196(2):145-53. PubMed ID: 11793365
[TBL] [Abstract][Full Text] [Related]
32. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
[TBL] [Abstract][Full Text] [Related]
33. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
[TBL] [Abstract][Full Text] [Related]
34. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
35. Axin prevents Wnt-3a-induced accumulation of beta-catenin.
Kishida M; Koyama S; Kishida S; Matsubara K; Nakashima S; Higano K; Takada R; Takada S; Kikuchi A
Oncogene; 1999 Jan; 18(4):979-85. PubMed ID: 10023673
[TBL] [Abstract][Full Text] [Related]
36. Adenomatous polyposis coli/beta-catenin interaction and downstream targets: altered gene expression in gastrointestinal tumors.
Clements WM; Lowy AM; Groden J
Clin Colorectal Cancer; 2003 Aug; 3(2):113-20. PubMed ID: 12952568
[TBL] [Abstract][Full Text] [Related]
37. Wnt/beta-catenin signaling.
Akiyama T
Cytokine Growth Factor Rev; 2000 Dec; 11(4):273-82. PubMed ID: 10959075
[TBL] [Abstract][Full Text] [Related]
38. Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas.
Zhai Y; Wu R; Schwartz DR; Darrah D; Reed H; Kolligs FT; Nieman MT; Fearon ER; Cho KR
Am J Pathol; 2002 Apr; 160(4):1229-38. PubMed ID: 11943708
[TBL] [Abstract][Full Text] [Related]
39. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors.
Lustig B; Jerchow B; Sachs M; Weiler S; Pietsch T; Karsten U; van de Wetering M; Clevers H; Schlag PM; Birchmeier W; Behrens J
Mol Cell Biol; 2002 Feb; 22(4):1184-93. PubMed ID: 11809809
[TBL] [Abstract][Full Text] [Related]
40. A protein knockdown strategy to study the function of beta-catenin in tumorigenesis.
Cong F; Zhang J; Pao W; Zhou P; Varmus H
BMC Mol Biol; 2003 Sep; 4():10. PubMed ID: 14516475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
